Gates Package — page 1214

4) [E] 2PM 1m NIH/NIA\ héoldman From: "Collins, Francis (NIH/OD) [E]" @od.nih.gov> To: "Hodes, Richard (NIH/NIA) [E]" @31.nia.nih.gov>, @bgc3.com" @bgc3.com> Cc: "Niranjan Bose" @bgc3.com>, "Jonah Goldman" @bgc3.com> Subject: RE: Thank you Date: Sat, 12 May 2018 11:29:48 -0400 Importance: Normal Dear Bill, We at NIH are very glad to work with you on this critical issue - and we're delighted that you have identified this as a major priority. All the best, Francis From: Hodes, Richard (NIH/NIA) [E] Sent: Friday, May 11, 2018 9:52 PM To: @bgc3.com Cc: Collins, Francis (NIH/OD) [E] @od.nih.gov>; Niranjan Bose @bgc3.com>; Jonah Goldman @bgc3.com> Subject: FW: Thank you Dear Bill, Thank you for the message and for the opportunity to work with you and the bgc3 team. Following our meeting with you last October, we have met with Bose, Scott, and Jonah in Bethesda, Santa Barbara, and last Friday in San Francisco. We strongly share your perspective on the critical importance of optimizing the generation, sharing, and analysis of data through interoperable platforms, and we look forward to working toward this priority as a part of the global coalition that is forming around this Alzheimer's effort. Thank you again for your leadership. Best regards Richard From: Bill Gates @bgc3.com> Sent: Friday, May 11, 2018 9:36 PM To: Collins, Francis (NIH/OD) [E] @od.nih.gov>; Hodes, Richard (NIH/NIA) [E] @31.nia.nih.gov> Cc: Niranjan Bose @bgc3.com>; Jonah Goldman @bgc3.com> Subject: Thank you Dear Francis and Richard, I wanted to thank both of you for your support and engagement as my team and I have explored opportunities to accelerate the discovery of scientific breakthroughs by enhancing access to Alzheimer's disease research data. I was great that Richard and Eliezer could participate in the working session last week. I understand that their input and engagement was extremely helpful. I appreciate the NIA's participation in this coalition of like-minded funders to help strengthen the data ecosystem for Alzheimer's disease. I am convinced that better leveraging the data being generated by studies funded by the NIH can accelerate the development of an effective treatment for Alzheimer's disease. I was excited to hear that the discussion was productive and that the group agreed to work together to improve data access, drive interoperability across existing Alzheimer's disease data platforms, and strengthen the data ecosystem for Alzheimer's.